Junjun Zhou
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CD70-Targeted Radiotheranostics: Now and Future.
Journal: Seminars in nuclear medicine
Published: August 06, 2025
Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
Journal: Nature communications
Published: April 03, 2025
CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 25, 2025
Radiotherapy-Associated Cellular Senescence and EMT Alterations Contribute to Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 08, 2024
Single-Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural-Like Progenitor Program Associated with the Efficacy of Radiotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 16, 2023
Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
Journal: Medical oncology (Northwood, London, England)
Published: October 14, 2013
Preliminary results of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a retrospective study of 364 patients.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: September 27, 2013
Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma.
Journal: Radiation oncology (London, England)
Published: August 02, 2013
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Journal: International journal of clinical oncology
Published: January 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026